TKNO vs. ACHV, VNRX, ABIO, AWH, ICCC, VANI, FONR, CLRB, OM, and BLUE
Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Achieve Life Sciences (ACHV), VolitionRx (VNRX), ARCA biopharma (ABIO), Aspira Women's Health (AWH), ImmuCell (ICCC), Vivani Medical (VANI), FONAR (FONR), Cellectar Biosciences (CLRB), Outset Medical (OM), and bluebird bio (BLUE). These companies are all part of the "medical" sector.
Alpha Teknova (NASDAQ:TKNO) and Achieve Life Sciences (NASDAQ:ACHV) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk, earnings and community ranking.
Alpha Teknova has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Achieve Life Sciences has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.
In the previous week, Achieve Life Sciences had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 6 mentions for Achieve Life Sciences and 0 mentions for Alpha Teknova. Achieve Life Sciences' average media sentiment score of 0.58 beat Alpha Teknova's score of 0.00 indicating that Achieve Life Sciences is being referred to more favorably in the news media.
13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 33.5% of Achieve Life Sciences shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by insiders. Comparatively, 2.0% of Achieve Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Achieve Life Sciences has a consensus price target of $17.25, indicating a potential upside of 277.46%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Achieve Life Sciences is more favorable than Alpha Teknova.
Achieve Life Sciences received 323 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 70.15% of users gave Achieve Life Sciences an outperform vote while only 30.00% of users gave Alpha Teknova an outperform vote.
Achieve Life Sciences has lower revenue, but higher earnings than Alpha Teknova. Achieve Life Sciences is trading at a lower price-to-earnings ratio than Alpha Teknova, indicating that it is currently the more affordable of the two stocks.
Achieve Life Sciences has a net margin of 0.00% compared to Alpha Teknova's net margin of -100.26%. Alpha Teknova's return on equity of -38.12% beat Achieve Life Sciences' return on equity.
Summary
Achieve Life Sciences beats Alpha Teknova on 11 of the 17 factors compared between the two stocks.
Get Alpha Teknova News Delivered to You Automatically
Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Teknova Competitors List
Related Companies and Tools
